Medical Practice

Controlled Sedation with Alphaxalone-Alphadolone

Br Med J 1974; 2 doi: https://doi.org/10.1136/bmj.2.5920.656 (Published 22 June 1974) Cite this as: Br Med J 1974;2:656
  1. M. A. E. Ramsay,
  2. T. M. Savege,
  3. B. R. J. Simpson,
  4. R. Goodwin

    Abstract

    Alphaxalone-alphadolone (Althesin), diluted and administered as a controlled infusion, was used as a sedative for 30 patients in an intensive therapy unit. This technique allowed rapid and accurate control of the level of sedation. It had three particularly useful applications: it provided “light sleep,” allowed rapid variation in the level of sedation, and enabled repeated assessment of the central nervous system.

    Sedation was satisfactory for 86% of the total time, and no serious complications were attributed to the use of the drug. Furthermore, though alphaxalone-alphadolone was given for periods up to 20 days there was no evidence of tachyphylaxis or delay in recovery time.

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe